Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.5B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Tesla
TSLA
|
+$951M |
| 4 |
Johnson & Johnson
JNJ
|
+$750M |
| 5 |
UnitedHealth
UNH
|
+$703M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$913M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$257M |
| 3 |
NVIDIA
NVDA
|
+$225M |
| 4 |
Vertiv
VRT
|
+$164M |
| 5 |
JPMorgan Chase
JPM
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.48% |
| 2 | Healthcare | 7.36% |
| 3 | Financials | 6.5% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FSNB
2976
DELISTED
Fusion Acquisition Corp. II
FSNB
| $733K | ﹤0.01% |
72,964
| – | – |
|
2977
Kforce
KFRC
$1.04B
| $732K | ﹤0.01% |
13,357
+275
| +2% | +$15.9K |
|
2978
Littelfuse
LFUS
$11.8B
| $728K | ﹤0.01% |
3,304
+524
| +19% | +$117K |
|
2979
Sterling Infrastructure
STRL
$16.6B
| $723K | ﹤0.01% |
22,035
+19,353
| +722% | +$569K |
|
|
TSVT
2980
DELISTED
2seventy bio
TSVT
| $722K | ﹤0.01% |
77,002
-6,332
| -8% | -$89.3K |
|
2981
Adtran
ADTN
$710M
| $721K | ﹤0.01% |
38,377
+17,852
| +87% | +$359K |
|
2982
HealthStream
HSTM
$871M
| $721K | ﹤0.01% |
29,025
+8,627
| +42% | +$207K |
|
|
BRKL
2983
DELISTED
Brookline Bancorp
BRKL
| $715K | ﹤0.01% |
50,530
+21,291
| +73% | +$285K |
|
2984
Vanda Pharmaceuticals
VNDA
$321M
| $715K | ﹤0.01% |
96,744
-2,558
| -3% | -$24.9K |
|
2985
Chefs' Warehouse
CHEF
$4.49B
| $713K | ﹤0.01% |
21,436
+7,464
| +53% | +$260K |
|
2986
MarineMax
HZO
$793M
| $713K | ﹤0.01% |
22,834
-3,453
| -13% | -$108K |
|
2987
Financial Institutions
FISI
$841M
| $711K | ﹤0.01% |
29,189
+6,213
| +27% | +$153K |
|
2988
El Pollo Loco
LOCO
$503M
| $706K | ﹤0.01% |
70,898
+19,995
| +39% | +$208K |
|
|
ARI
2989
Apollo Commercial Real Estate
ARI
$889M
| $706K | ﹤0.01% |
65,608
+28,025
| +75% | +$306K |
|
2990
Primerica
PRI
$9.92B
| $705K | ﹤0.01% |
4,968
-998
| -17% | -$139K |
|
2991
Southside Bancshares
SBSI
$976M
| $704K | ﹤0.01% |
19,550
+9,038
| +86% | +$321K |
|
2992
Enerpac Tool Group
EPAC
$1.9B
| $702K | ﹤0.01% |
27,589
+9,046
| +49% | +$218K |
|
2993
Collegium Pharmaceutical
COLL
$1.16B
| $701K | ﹤0.01% |
30,222
+3,886
| +15% | +$78.4K |
|
|
AAN
2994
DELISTED
The Aaron's Company Inc
AAN
| $700K | ﹤0.01% |
58,568
+32,895
| +128% | +$352K |
|
|
ESGR
2995
DELISTED
Enstar Group
ESGR
| $697K | ﹤0.01% |
3,018
+433
| +17% | +$88.2K |
|
2996
Jack in the Box
JACK
$329M
| $697K | ﹤0.01% |
10,217
+4,374
| +75% | +$336K |
|
2997
Oil States International
OIS
$507M
| $696K | ﹤0.01% |
93,272
+10,320
| +12% | +$63.9K |
|
|
KW
2998
DELISTED
Kennedy-Wilson Holdings
KW
| $695K | ﹤0.01% |
44,210
+5,244
| +13% | +$84.3K |
|
2999
PUT
Teladoc Health
TDOC
$1.22B
| $695K | ﹤0.01% |
+29,400
| New | +$793K |
|
3000
iShares Core S&P Mid-Cap ETF
IJH
$126B
| $694K | ﹤0.01% |
14,340
-152,690
| -91% | -$7.38M |
|
Similar funds
Barclays's Q4 2022 Portfolio in Review
As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $128B of net new capital in Q4 2022, opening 798 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.
- Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
- Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
- Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
- Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
- Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
- Barclays opened 798 new positions and closed 385 in Q4 2022.
- Barclays's portfolio value rose 144% quarter-over-quarter to $223B.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.